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Background. Adverse maternal environments may predispose the oﬀspring to metabolic syndrome in adulthoods, but the
underlying mechanism has not been fully understood. Methods. Maternal hyperglycemia was induced by streptozotocin (STZ)
injectionwhilecontrol(CON)ratsreceivedcitratebuﬀer.Litterswereadjustedtoeightpupsperdamand thenweaned tostandard
diet. Since 13 weeks old, a subset of oﬀspring from STZ and CON dams were switched to high fat diet (HFD) for another 13
weeks. Glucose and insulin tolerance tests (GTT and ITT) and insulin secretion assay were performed; serum levels of lipids and
leptin were measured. Hepatic fat accumulation and islet area were evaluated through haematoxylin and eosin staining. Results.
STZ oﬀspring exhibited lower survival rate, lower birth weights, and growth inhibition which persisted throughout the study.
STZ oﬀspring on HFD showed more severe impairment in GTT and ITT, and more profound hepatic steatosis and more severe
hyperlipidemia compared with CON-HFD rats. Conclusions.O ﬀspring from diabetic dams would be prone to exhibit low birth
weight and postnatal growth inhibition, but could maintain normal glucose tolerance and insulin sensitivity. HFD accelerates
development of insulin resistance in the oﬀspring of diabetic dams mainly via a compensatory response of islets.
1.Introduction
Metabolic syndrome (MetS) is a clustering of metabolic dis-
orders including hyperglycemia, hypertension, dyslipidemia,
overweight, and central obesity, with insulin resistance as the
central feature of this syndrome [1]. A global increase in the
prevalence of MetS has been found in the last decades due
to the worldwide epidemic of obesity [2, 3]. The risk of the
MetS depends on genetic susceptibility but is modulated by
pre- and postnatal environmental factors. A growing body
of evidence suggests that adverse environmental conditions
during crucial periods of development may predispose
individuals to develop diﬀerent components of the MetS
in adulthood [4]. Of particular note is maternal diabetes,
including type 1 and type 2 diabetes and gestational diabetes
mellitus(GDM).Anoverallincreasingprevalenceofdiabetes
indicates an emergence of diabetes among childbearing
women.Duringpregnancy,especiallyduringcriticalwindow
periods for organogenesis and fetal development, unsatis-
factory glycemic control is known to increase the incidence
of severe obstetrical complications, including preeclampsia,
macrosomia, and Caesarean section. Additionally, intrauter-
ine exposure to a hyperglycemic environment predisposes
the oﬀspring to develop glucose intolerance and obesity in
early life [5–9]. These epidemiological and clinical studies
have strongly certiﬁed that maternal pregnancy with hyper-
glycemia was a major risk factor for the development of
MetS in their oﬀspring [10, 11]. Thus, it seems that the
key point is to evaluate how maternal hyperglycemia during
pregnancy aﬀects fetal growth and organ development, and
whether improved glycemic control may ameliorate preg-
nancy outcome.2 Experimental Diabetes Research
Animal models provide good opportunities to observe
the long-term outcomes of maternal hyperglycemia during
periods of pregnancy and lactation in the oﬀspring and
to further elucidate the underlying mechanism. A vari-
ety of such murine models have been established using
pregnant animals by administration of streptozotocin, an
antibiotic agent with speciﬁc toxicity to pancreatic β-cells
[12–21]. However, the majority of these animal models were
employed to evaluate mild diabetic eﬀects, and mostly in
middle or later stages of pregnancy with hyperglycemia.
In humans, severe hyperglycemia has been reported in
some pregnant women with uncontrolled diabetes, where
microsomia is most often observed [22]. In this study, we
investigated maternal-fetal outcomes of the severe maternal
hyperglycemia (>20mM) during the whole periods of
pregnancy and lactation and assessed the metabolic features
in their oﬀspring.
2.MaterialsandMethods
2.1. Animals and Treatment. Sprague-Dawley rats (8-week-
old, weighing 200–250g) were used in this study. All rats
were housed individually in wood-chip-bedded plastic cages
at constant temperature (22 ± 1◦C) and humidity (60 ± 5%)
witha12-hour light-darkcycle.Theyhadfreeaccesstowater
and a standard chow diet (10% of energy from fat, SLAC
laboratory animal, China). After mating, the ﬁrst day of
gestation (G0) was deﬁned by the presence of spermatozoids
in vaginal smears. Pregnant rats were made diabetic by
a single intraperitoneal injection of streptozotocin (Sigma,
40mg/kg body weight) dissolved in 0.1M citrate buﬀer, pH
4.3, on G0, and control rats were injected with the same
volume of citrate buﬀe r .M a t e r n a lb l o o dg l u c o s el e v e l sw e r e
monitored by glucose meter (One Touch, Johnson, USA).
Blood samples were obtained by cutting oﬀ the tip of tails
and squeezing gently on days of G5, G12, and G19, as well
as on day 10 of lactation (L10). Only those rats with blood
glucose levels above 20mM on all four time points were
designated as severe maternal hyperglycemia. A total of 10
hyperglycemic and 6 control dams were included in the
study. All rats were allowed to deliver spontaneously and
litter size was examined, and the pups were weighed within
12hours after birth and then returned to their mothers
immediately. On the ﬁrst day, litters were adjusted to 8pups
per dam. To exclude the inﬂuence of female hormones, only
male oﬀsprings were used in the present study. Oﬀsprings
were fed the same standard chow diet at 3weeks of age after
weaning and body weights were recorded biweekly. From
13weeks of age, half of the oﬀs p r i n g si nb o t hg r o u p sw e r e
switchedtohighfatdiet(HFD,45%ofenergyfromfat,SLAC
laboratory animal, China), and the rest were maintained
on standard chow diet, and thereby four separate adult
oﬀspring groups were studied: CON oﬀspring fed standard
chow diet (CON-S), CON oﬀspring fed HFD (CON-H),
STZ oﬀspring fed standard chow diet (STZ-S), and STZ
oﬀspring fed HFD (STZ-H). All oﬀspring were sacriﬁced at
25weeks of age, and plasma was immediately isolated from
blood samples by centrifugation at 3000rpm for 20minutes
at 4◦Ca n ds t o r e da t−80◦C for analysis. Epididymal white
adipose tissue, liver, and pancreas were quickly removed and
dissected free of connective tissues and used for RNA and
protein extraction, or for histological study. All experimental
procedures were approved by the Institutional Animal Care
and Use Committee of Chongqing Medical University.
2.2. Glucose Tolerance Tests, Insulin Tolerance Tests, and
Insulin Releasing Tests. Glucose tolerance tests (GTTs) were
performed at 8 and 24weeks of age, and insulin tolerance
tests (ITTs) and insulin releasing tests (IRTs) were performed
at 24weeks. After 16 hours fasting, GTT was performed as
follows: after collecting blood from the tail (0 time), the
rats received glucose (2g/kg body weight) via intraperitoneal
injection and blood glucose was measured at 0, 15, 30,
60, 120minutes points as previously reported. IRT was
determined during the GTT, at 0, 30, 60, 90minutes, and
an aliquot of the blood sample (>100μL) was collected
for serum by centrifugation. Serum insulin was determined
with a highly speciﬁc enzyme-linked immunosorbent assay
(ELISA) kits as per the manufacturer’s directions (R&D,
USA). ITT was performed after 4hours fasting, human
recombinant insulin (1units/kg, Novo Nordisk, Denmark,)
was intraperitoneally injected and blood glucose was mea-
sured at 0, 30, 60, 90, 120 minutes.
2.3. Serum Assays. Serum leptin was determined with a
rat leptin ELISA immunosorbent assay kit (R&D, USA).
Serum total cholesterol (TC), triglyceride (TG), high-density
lipoprotein (HDL), and low-density lipoprotein (LDL) were
measured with Biochemical Analyzer (SIEMENS ADVIA
2400 Chemistry System, Germany) [23].
2.4. Tissue Collection and Histological Studies. Liver, pan-
creas, gonadal and retroperitoneal white adipose tissue were
removed, washed with cold saline (0.9%), and weighed
immediately. The liver and pancreas tissues were ﬁxed in
10% formalin for 24hours, ethyl alcohol dehydrated, and
embedded in paraﬃn .T i s s u e sw e r ec u tt o6ﬁ x e ds e c t i o n s
(5μm), stained with hematoxylin and eosin (H&E). Three
ﬁxed pancreas sections per animal and three diﬀerent rats
in each group were studied. Sections were photoed by
microscope at a magniﬁcation of 200x (Olympus BX51,
Japan) and pancreatic islets area was quantiﬁed using Image
J1 . 4 0s o f t w a r e .
2.5. Statistical Analysis. All data were analyzed by using SAS
9.1 software(SAS,USA).Survivalrate wascomparedby rank
sum test. Two group’s data were expressed as mean ± SEM
and compared by paired sample t-test analysis of variance
(ANOVA). Two-way ANOVA was used to assess interaction
between maternal glycemic type and oﬀspring fed-type. A P
value <0.05 was considered statistically signiﬁcant.
3. Results
3 . 1 .AS i n g l eD o s eo fS T ZI n d u c e sP e r s i s t e n tH y p e r g l y c e m i a .
Among the 15 pregnant rats injected with STZ, only 10
rats (66.7%) met our criteria with blood glucose levels allExperimental Diabetes Research 3
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Figure 1: Maternal blood glucose levels in citrate buﬀer-treated
control dams (CON, n = 6) or streptozotocin-treated dams (STZ,
n = 10) on days 5, 12, and 19 of the gestation (G5, G12, and G19)
and day 10 of lactation (L10). Data are expressed as means ± SEM;
∗∗P < 0.01 versus CON.
above 20mM throughout gestational and lactation periods,
and glucose levels were 23.3 ± 0.4mM, 22.8 ± 0.2mM,
23.1 ± 2.3mM,and20.9 ± 2.4mM on G5, G12, G19, and
L10, respectively. However, citrate buﬀer-treated CON dams
displayed normal blood glucose levels, which were 5.6 ±
0.8mM,5.2 ± 0.4mM,5.8 ± 0.3mM,and5.9 ± 0.8mM,on
G5, G12, G19, and L10, respectively (Figure 1).
3.2. Severe Maternal Hyperglycemia during Gestation Alters
Perinatal Outcomes. Compared with CON oﬀspring, birth
weightofSTZoﬀspringtendedtobereduced(STZoﬀspring,
6.0±0.2g;CONoﬀspring 6.9±0.1g;P<0.01, Figure 2(a)).
However, severe maternal hyperglycemia induced by STZ
administration did not signiﬁcantly alter the litter size (STZ,
8.6±0.8; CON, 10.8±1.0, P = 0.1143, Figure 2(b)). Further-
more, the survival rate from STZ oﬀsprings within the ﬁrst
weekofpostpartumwassigniﬁcantlylowerthanthatofCON
oﬀspring (X2 = 6.3, P<0.05, Figure 2(c)). Other perinatal
outcomes did not diﬀer between the two groups.
3.3. Severe Maternal Hyperglycemia during Gestation and
Lactation Impairs Postnatal Growth Rate in the Oﬀspring.
The STZ oﬀspring had signiﬁcantly lower body weight than
CON oﬀspring at the ﬁrst 12 weeks of age when fed standard
chow diet since weaning (Figure 3(a)). The body weight
diﬀerence between two groups still existed when fed HFD for
another 13 weeks, and CON-H oﬀspring were 9.6% heavier
than STZ-H oﬀspring (Figure 3(b)). These data indicated
that severe maternal hyperglycemia during the periods of
gestation and lactation impaired postnatal growth in their
oﬀspring.
3.4. Severe Maternal Hyperglycemia during Gestation and
Lactation Alters Glucose Disposal and Insulin Sensitivity in
the Oﬀspring. At the age of 8weeks, both STZ and CON
oﬀsprings fed with chow diet exhibited similar pattern
as to GTT (Figure 4(a)), which persisted to the age of
24weeks (Figure 4(b)). However, when maintained on HFD,
STZ-H rats displayed signiﬁcantly higher glucose levels at
30min during GTT when compared with CON-H oﬀspring
(Figure 4(b)). Meanwhile, serum insulin levels at 30min
during GTT were signiﬁcantly higher in STZ-H oﬀspring
(Figure 4(c)). To further examine insulin sensitivity in these
rats, we performed insulin tolerance test. Thirty minutes
afterinsulininjection,bloodglucoselevelsofSTZ-Hanimals
were signiﬁcantly higher than those of other counterparts
(Figure 4(d)). These data suggested that severe maternal
hyperglycemia during periods of gestation and lactation
produced metabolic dysfunction in their oﬀspring only on
high fat diet but not on normal diet.
3.5. Severe Maternal Hyperglycemia during Gestation and
Lactation Alters Islet Morphology in the Oﬀspring. We then
examined islet area to explore the mechanisms of impaired
insulin sensitivity and secretion. As shown in Figure 5(a),
the islet size did not diﬀer between STZ and CON oﬀspring
on standard chow diet. HFD feeding increased the islet sizes
in both CON and STZ oﬀspring. Interestingly, islet sizes
of STZ-H were signiﬁcantly larger than those of CON-H
(Figures 5(a) and 5(b)). These results suggested that high
fat diet might induce a compensatory response to maintain
normal islet function in STZ oﬀspring.
3.6. Severe Maternal Hyperglycemia during Gestation and
Lactation Alters Lipid Metabolism in the Oﬀspring. General
biochemical characteristics of the animals at the age of
25 weeks were summarized in Table 1. Even HFD feeding
increased the sum of WAT in both CON and STZ oﬀspring,
STZ oﬀspring had lower WAT than CON oﬀspring. As
expected, serum leptin level of the two groups tended to
be the similar trends. Compared with other three groups,
STZ-H animals had signiﬁcantly higher levels of TG and
LDL, while signiﬁcantly lower HDL level (Table 1). In STZ-
H animals, there were more manifest hepatic steatosis, which
was correspondent with the obvious dyslipidemia in this
group (Table 1 and Figure 6). Taken together, these results
suggested severe maternal hyperglycemia during pregnancy
and lactation induced hepatic steatosis and hyperlipidemia
only in their oﬀspring fed with HFD.
4. Discussion
Fetal and early postnatal exposure to excess nutritional
environmentisawell-deﬁnedriskfactorforthedevelopment
of MetS [11, 24, 25]. Unlike the majority of previous studies
which mainly evaluated the eﬀects of mild hyperglycemia
during the middle and later stages of pregnancy, we inves-
tigated maternal-fetal outcomes of the severe hyperglycemia
(>20mM) during the whole periods of pregnancy and
lactation. As expected, severe diabetic pregnancies lead to
disadvantage perinatal outcomes, as reﬂected by increased
perinatal mortality. In addition, our model results in a lower
birth weight and impaired postnatal growth in survived4 Experimental Diabetes Research
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Figure 2: Maternal STZ treatment during gestation alters perinatal outcomes. Birth weight (a), litter size (b), and survival rate of pups at
7-day-age (c) were monitored for the oﬀspring from citrate buﬀer-treated control dams (CON, n = 54) or streptozotocin-treated dams
(STZ, n = 71). Values are means ± SEM; statistically signiﬁcant diﬀerences are indicated by
∗P < 0.05 and
∗∗P < 0.01 compared with CON.
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Figure 3: Severe maternal hyperglycemia impairs postnatal growth rate in the oﬀspring. (a) Bodyweight gain in CON oﬀspring and STZ
oﬀspring from birth to 12 weeks under standard chow diet feeding after weaning, data were mean ± SEM,
∗P < 0.05 versus STZ; (b)
bodyweight gain in CON oﬀspring and STZ oﬀspring under standard chow diet or high fat diet feeding from 13 weeks to 25 weeks. CON-S:
CON oﬀspring fed with standard chow diet; CON-H: CON oﬀspring fed with high fat diet; STZ-S: STZ oﬀspring fed with standard chow
diet; STZ-H: STZ oﬀspring fed with high fat diet. Data were presented as means ± SEM.
∗P < 0.05 versus CON-S, #P < 0.05 versus STZ-H.
n = 6–11 in each group.
oﬀspring of diabetic mothers, and the change in weight
gain persisted after weaning and throughout their entire
life. When maintained on standard chow diet, oﬀsprings
from diabetic mothers exhibited relatively normal glucose
tolerance as their counterparts from normal glycemic dams.
However, when these rats were fed with HFD, they displayed
signiﬁcantlyimpairedglucosetolerance,severeinsulininsen-
sitivity and fatty liver. This is, to our knowledge, the ﬁrst
report that oﬀspring from diabetic mothers respond dif-
ferently when challenged with high caloric diets during
adulthood and are susceptible to HFD-induced metabolic
perturbation.
Although numerous experimental studies have been
performed as insulin resistance in oﬀspring from diabetic
maternal rats after administration of STZ, results from this
model are inconsistent and divergent [12, 15, 16, 19, 20, 26–
30]. Discord phenotypes in the oﬀspring born to diabetic
dams may possibly be attributable to the doses of STZ, the
severity of hyperglycemia, and time windows and duration
occurring during pregnancy. Plagemann et al. used a ratExperimental Diabetes Research 5
Table 1: Metabolic parameters of CON oﬀspring and STZ oﬀspring at the age of 25weeks.
CON-S CON-H STZ-S STZ-H
Body weight (g) 469.5 ± 20.9 492.7 ± 19.3 418.7 ± 12.6 449.1 ±19.4∗,#
Sum of WAT(g) 20.9 ±1.92 7 .5 ±0.81 3 .3 ±0.71 7 .6±1.2∗,#
Insulin (ng/ml) 0.23 ±0.04 0.39 ±0.04 0.25 ±0.05 0.42±0.05∗
Leptin (ng/ml) 1.37 ±0.12 1.95 ±0.13 1.31 ±0.21 1.53 ±0.40
TC (mM) 1.63 ±0.05 2.27 ±0.35 1.78 ±0.37 2.41 ±0.11∗
TG (mM) 5.32 ±1.02 4.85 ±1.07 4.50 ±2.49 8.15 ±1.64∗,#
HDL (mM) 0.80 ±0.10 1.11 ±0.11 0.77 ±0.06 0.59 ±0.08∗,#
LDL (mM) 0.31 ±0.02 047 ±0.08 0.37 ±0.14 0.64 ±0.06∗,#
SumofWAT,sumofretroperitonealandgonadalwhiteadiposetissue;TC:totalcholesterol;TG:triglyceride;HDL:high-densitylipoprotein;LDL:low-density
lipoprotein. CON-S: CON oﬀspring fed with standard chow diet; CON-H: CON oﬀspring fed with high fat diet; STZ-S: STZ oﬀspring fed with standard chow
diet; STZ-H: STZ oﬀspring fed with high fat diet. Data were presented as means ± SEM. ∗P < 0.05 versus STZ-S, #P < 0.05 versus CON-H, n = 6–11 in each
group.
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Figure 4: Severe maternal hyperglycemia during gestation and lactation produces metabolic dysfunction only in STZ oﬀspring on HFD. (a)
Glucose tolerance test (GTT) at 8 weeks between CON oﬀspring and STZ oﬀspring under standard chow diet feeding. (b) GTT at 24 weeks
in CON oﬀspring and STZ oﬀspring under standard chow diet or high fat diet feeding. (c) Insulin tolerance test at 25 weeks in these four
groups. (d) Insulin releasing test determined during the GTT. CON-S: CON oﬀspring fed with standard chow diet; CON-H: CON oﬀspring
fed with high fat diet; STZ-S: STZ oﬀspring fed with standard chow diet; STZ-H: STZ oﬀspring fed with high fat diet. Data were presented
as means ± SEM.
∗P < 0.05 versus STZ-S, #P < 0.05 versus CON-H, n = 6–11 in each group.6 Experimental Diabetes Research
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Figure 5: Severe maternal hyperglycemia during gestation and
lactation alters islet morphology and lipid metabolism in the
oﬀspring. (a) Histological sections of hematoxylin and eosin
(H&E)-stainedpancreasofCONoﬀspringandSTZoﬀspringunder
standard chow (S) or high fat diet (H) feeding. Sections were
examined by light microscopy at a magniﬁcation of 200x; (b) islets
areas were quantiﬁed using Image J 1.40 software. Values were
means ± SEM;
∗P < 0.05 versus STZ-S, #P < 0.05 versus CON-
H; n = 5 in each group.
m o d e lw i t hm o d e r a t ei m p a i r m e n ti ng l u c o s et o l e r a n c ei n
pregnant rats by application of low dose of STZ on the
day of conception and found that oﬀspring of these mildly
diabetic mothers developed early overweight and hyperin-
sulinemia accompanied by early signs of insulin resistance
[27]. With the similar protocol, the ﬁndings were further
conﬁrmed by several other studies [16, 29]. L´ opez-Soldado
and Herrera showed that rats displayed a diﬀerent response
to STZ when administered at the onset of pregnancy. At the
dose of 35mg/kg, STZ induced both mild (glucose levels
around 11mM) and severe (22mM) hyperglycemia, and
CON-S CON-H
STZ-H STZ-S
Figure 6: Severe maternal hyperglycemia during gestation and
lactation alters liver fat accumulation in the oﬀspring. Histological
sections of hematoxylin and eosin (H&E)-stained liver of CON
oﬀspring and STZ oﬀspring under standard chow diet feeding.
Sections were examined by light microscopy at a magniﬁcation of
200x; CON-S: CON oﬀspring fed with standard chow diet; CON-
H: CON oﬀspring fed with high fat diet; STZ-S, STZ oﬀspring fed
with standard chow diet; STZ-H: STZ oﬀspring fed with high fat
diet. n = 5 in each group.
the phenotypes of oﬀspring born to these moderately or
severely hyperglycemic dams were quite diﬀerent. Oﬀspring
from moderately hyperglycemic dams were macrosomic,
while pups from severely hyperglycemic mothers were
smaller, weighed less, and had slightly impaired glucose
tolerance [16]. Timing is another important factor. STZ
administration before pregnancy may aﬀect fertility and
impair embryo development during the preimplantation
period [31]. However, if STZ was injected after pregnancy,
the chemical may cross the placenta and directly aﬀect the
fetus. Therefore, we choose to inject STZ at the onset of
pregnancy and select those rats with severe hyperglycemia
to mimic the human pregnant women with uncontrolled
diabetes. In current study, we observed that oﬀspring born
to and nurtured by mothers with severe diabetes exhibited
a lower birth weight and impaired postnatal growth, and
this change in weight gain persisted after weaning and
throughout the entire study, agreeing with previous reports
[15, 16]. To determine if animals born to mothers with
severe diabetes have similar response with their counterparts
from normal glycemic dams after high energy challenge,
w ef e dr a t sw i t hH F D .A se x p e c t e d ,o ﬀspring from both
STZ and CON mothers showed the same extent of weight
gain, although the ﬁnal body weight was still lower than
that of CON oﬀspring after 13 weeks of HFD. Importantly,
compared with CON oﬀspring, STZ oﬀspring displayed
moresevereimpairmentinglucosetolerancetest,andgreater
insulin insensitivity, dyslipidemia, and hepatosteatosis on
HFD, while the metabolic dysfunctions were not obvious
in STZ oﬀspring on standard chow diets [32]. All theseExperimental Diabetes Research 7
ﬁndingsindicatedthatseverematernalhyperglycemiaduring
periods of both gestation and lactation might contribute to
the increased risk for developing MetS in later life of their
oﬀspring.
The mechanisms underlying how maternal hyper-
glycemia during early life stage aﬀects organ development,
fetal and postnatal growth and metabolic homeostasis in
oﬀspring remain unclear. However, an adaptive compen-
satory response of pancreatic islets may provide a tentative
explanation for their features in glucose homeostasis. It is
generally accepted that when fetus exposed to hyperglycemic
environment, a large number of maternal glucose would
crossthroughtheplacentalbarrierintothefetus,tostimulate
the proliferation of fetal islet cells, and thereby insulin
secretion was increased and fetal hyperglycemia and hyper-
insulinemia were produced. On the other hand, maternal
hyperglycemia can reduce the oxygen supply from placenta
to the fetus, and fetal hyperglycemia may induce increase
in fetal oxygen consumption. The chronic hypoxia leads
to intrauterine fetal growth restriction. Rodr´ ıguez reported
that immediately after parturition, pancreatic islets in pups
from mildly and severely diabetic mothers were smaller than
those in neonates from nondiabetic controls but the size
was rapidly normalized when exposure to high blood sugar
had disrupted [33]. The similar results were also observed
in the Goto-Kakisaki (GK) rat, a well-deﬁned genetic model
for type 2 diabetes [34]. When the oﬀspring from diabetic
mothers were fed relatively-healthy diets, these animals can
maintain normal glucose levels. The phenomenon was also
observed in our current studies and was in agreement with
some clinical observations [35, 36]. Moreover, our data
presented additional evidence that when oﬀspring born to
and nurtured by severe diabetic mothers were fed with high-
fat-diet, a mild, but signiﬁcant increase in islets area was
found, which presumably was via a compensatory response
of β-cell mass [37]. Therefore, we speculated that exposure
in utero to a severe hyperglycemia environment exacerbates
the development of insulin resistance in oﬀspring with high
fat feeding.
In summary, we observed that severe maternal diabetes
during gestation and lactation lead to microsomic oﬀspring
andpostnatalgrowthinhibition.Theseanimalscanmaintain
normoglycemia and relatively normal insulin sensitivity
under standard diet. HFD accelerates the development of
insulin resistance, dyslipidemia, and hepatosteatosis in the
oﬀspring of diabetic dams. Thus, these results reinforce the
importance for women to avoid exposure to hyperglycemia
before they become pregnant. This rat model with moderate
amountofSTZcouldalsobeusedtostudyotherpathophysi-
ological consequences of the maternal diabetic conditions on
the next generation.
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